North America Contrast Media Injectors Market Key Companies and SWOT Analysis by 2027

The North America contrast media injectors market is expected to reach US$ 507.8 Mn in 2027 from US$ 271.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.3% from 2019-2027.

The growth of the market is driven by the factors such as, increasing number of approvals for contrast agents and increasing number of patients suffering with chronic diseases. However, the market is likely to get impacted due to side effects associated with the contrast media agents and shortage of skilled professionals in the region.

In an aging society where chronic diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Chronic diseases can be defined as medical conditions that lasts for one year or more and requires ongoing medical attention or limit activities of daily living.

Chronic diseases such as cancer, heart diseases, musculoskeletal diseases and others are the leading causes of death and disability that requires several imaging modalities for diagnostic and treatment monitoring purposes. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs.

According to the Centers for Disease Control & Prevention (CDC), 6 in 10 adults in the US are suffering with chronic diseases. Moreover, the CDC also reports that 4 in 10 adults have two or more chronic cases. Moreover, according to the U.S. Department of Health and Human Services, 133 million Americans are living with one chronic disease.

Moreover, they account for 81% of hospital admissions; 91% of all prescriptions filled; and 76% of all physician visits. The U.S. employers and employees are paying for the high costs of chronic disease through the increase in health costs associated with greater demand for and use of health care services. Thus, the increasing pool of patients suffering with chronic diseases that demands medical imaging techniques are likely to be responsible to boost the growth of contrast media injectors market in the US over the coming years.

US is expected to lead the market in the North America region owing to increasing number of approvals for contrast agents and increasing number of patients suffering with chronic diseases. However, side effects associated with the contrast media agents is anticipated to restrain the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

Mexico Contrast Media Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

NORTH AMERICA CONTRAST MEDIA INJECTORS – MARKET SEGMENTATION

By Product

• Injector Systems
  • MRI Injector Systems
  • CT Injector Systems
  • Angiography Injector Systems
• Consumables
  • Injector Heads
    • Single Head Injectors
    • Dual Head Injectors
    • Syringe less Injectors
  • Tubing
  • Syringes
  • Other Consumables
• Accessories

By Application

• Interventional Cardiology
• Interventional Radiology
• Radiology

By Geography

• North America

  • US
  • Canada
  • Mexico

Company Profiles

• Boston Scientific Corporation
• Shenzhen Xinguan Electromechanical Co. Ltd.
• ulrich GmbH & Co.KG.
• APOLLO RT Co. Ltd.
• Bracco Imaging S.p.A.
• Guerbet SA
• Cook Medical Incorporated
• Smiths Medical
• Sino Medical-Device Technology Co., Ltd.,
• Bayer AG
• Nemoto Kyorindo Co., Ltd.
• General Electric
• AngioDynamics.

North America Contrast Media Injectors Report Scope